MYOKARDIA

CAMZYOS is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms... Learn more about CAMZYOS™ Risk Evaluation and Mitigation Strategy (REMS), including how to get certified and how to manage your REMS tasks online.

Also known as: CAMZYOS, CAMZYOS REMS, MyoKardia, Inc.